|
|
Cologne, December 2015 |
|
Dear colleagues and friends, We are currently updating ISHL10 and will come back to you shortly with the first version of the program. We would like to wish you a wonderful holiday season, a Merry Christmas and a fantastic new year! |
|
This year’s ASH clearly indicated that immunotherapy creates new therapeutic opportunities for patients with Hodgkin Lymphoma. Immunotherapy will also be one major focus of our next International Hodgkin Symposium (ISHL10). |
|
You find details about ISHL10 on www.hodgkinsymposium.org or you contact our organizational team at info@hodgkinsymposium.org. |
|
Please don’t forget your early registration! |
|
We look forward to welcoming you in Cologne in 2016. Cordially Andreas Engert, MD, Congress and GHSG Chairman Boris Böll, MD, Congress Secretary Bastian von Tresckow, MD, Congress Secretary |
|
Please do not reply directly to this message. If you would like more information on the 10ᵗʰ International Symposium on Hogkin Lymphoma, or have additional questions please contact Gabriele Hanke (info@hodgkinsymposium.org). Please add enews@hodgkinsymposium.org to your address book to prevent spam filters from blocking these e-mails. 10ᵗʰ International Symposium on Hodgkin Lymphoma Tel. +49 (0)221-478 5933 E-Mail: info@hodgkinsymposium.org Legal Entity: The University Hospital of Cologne is a Public Law Institution. For more information please click here . |